Bullish option flow detected in Bristol Myers Squibb with 3,829 calls trading, 1.0x expected, and implied vol increasing almost 2 points to 20.80%. Nov-23 52.5 calls and 11/10 weekly 51 puts are the most active options, with total volume in those strikes near 2,500 contracts. The Put/Call Ratio is 0.58. Earnings are expected on February 2nd.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on BMY:
- Stifel downgrades Ventyx Biosciences after ‘disappointing’ VTX958 data
- Leerink downgrades Mirati to Market Perform as focus remains on acquisition
- Wells downgrades Ventyx to Equal Weight on ‘major setback’
- Mirati Therapeutics downgraded to Hold on pending buyout at Stifel
- Bristol Myers to present research across portfolio, pipeline at ASH Meeting
